A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of extracellular proteases involved in a variety of physiological and cellular processes such as cell migration, angiogenesis, and extracellular matrix (ECM) remodeling. Each member of the ADAMTS family has distinct but overlapping roles and activities, often regulated through complex cellular signaling pathways. ADAMTS-12, for instance, functions primarily in the modulation of the ECM and has been shown to interact with specific substrates like aggrecan and versican. The protease is usually synthesized as a latent pro-enzyme that undergoes a series of post-translational modifications and activations to become fully functional. It's regulated through a variety of endogenous inhibitors, substrate availability, and signaling pathways that could either stimulate or inhibit its enzymatic activity.
ADAMTS-12 activators belong to a distinct class of molecules designed to enhance or modulate the function of ADAMTS-12 through various mechanisms. Some of these activators may work indirectly by inhibiting the pathways that oppose ADAMTS-12 activity, thereby creating a cellular environment conducive to its function. Others could influence epigenetic markers that control ADAMTS-12 gene expression, thereby increasing its cellular availability. In addition, certain molecules could stabilize the ECM in a way that favors ADAMTS-12 enzymatic action or promote post-translational modifications that enhance its stability or substrate affinity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
As a TGF-β inhibitor, it could potentially upregulate ADAMTS-12 by preventing its downregulation, as TGF-β signaling often suppresses ADAMTS expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
This HDAC inhibitor may facilitate ADAMTS-12 gene expression by altering the epigenetic landscape. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
An MMP inhibitor that could help in maintaining the ECM substrates available for ADAMTS-12 activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
As an Nrf2 activator, it might influence ADAMTS-12, particularly under conditions of oxidative stress. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
This hydroxylase inhibitor could affect post-translational modifications of ADAMTS-12, thereby potentially influencing its stability or activity. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A gamma-secretase inhibitor that interferes with Notch signaling could indirectly influence ADAMTS-12 expression or activity. | ||||||
Esculetin | 305-01-1 | sc-200486 sc-200486A | 1 g 5 g | $44.00 $212.00 | 7 | |
A naturally occurring coumarin that has been shown to inhibit LOX activity. Lysyl oxidase (LOX) inhibitors target the enzyme responsible for cross-linking collagen and elastin fibers in the extracellular matrix (ECM) and stabilize the ECM, affecting the substrate availability for ADAMTS. | ||||||